A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients-Reference-Cited by-同舟云学术

A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients

Published:2010-08-05 Issue:10 Volume:101 Page:2227-2233
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Ishiguro Takahiro,Kawai Shigeto,Habu Kiyoshi,Sugimoto Masamichi,Shiraiwa Hirotake,Iijima Shigeyuki,Ozaki Shuji,Matsumoto Toshio,Yamada-Okabe Hisafumi

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01663.x/fullpdf

Reference33 articles.

1. The use of novel agents in the treatment of relapsed and refractory multiple myeloma;Laubach;Leukemia,2009

2. Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma;Lonial;Br J Haematol,2009

3. Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib;Mitsiades;Semin Hematol,2009

4. Monoclonal antibodies for cancer immunotherapy;Weiner;Lancet,2009

5. Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24;Ozaki;Blood,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies;Cancers;2020-10-19

2. Multiple Myeloma: What Do We Do About Immunodeficiency?;Journal of Cancer;2019

3. Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma;The Journal of Biochemistry;2018-09-18

4. Targeting the immune niche within the bone marrow microenvironment: The rise of immunotherapy in Multiple Myeloma;Current Cancer Drug Targets;2017-02-14

5. Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro;Journal of Biological Chemistry;2017-02